Neil Harris Cohen, Director at Chemomab Therapeutics Ltd. (CMMB), bought 2,000 shares at $3.19 ($6K) on 2022-05-18, disclosed to the SEC on 2022-05-19.
Open-market purchase of $6k CMMB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| CMMB | BUY | 2022-03-15 | $26K | — | Filing → |
| CMMB | BUY | 2021-12-08 | $15K | — | Filing → |
| CMMB | BUY | 2021-03-26 | $200K | — | Filing → |